Best Healthcare Stocks — The YouTuber Consensus
Which healthcare and biotech stocks do finance YouTubers recommend with real analysis? This list ranks the consensus across the sector.
TOTopicus25“The YouTuber highly recommends Topicus, citing its high growth rates, shareholder-friendly approach (no stock-…”
TMTransmedics25“The YouTuber is buying Transmedics, believing it to be a cheap growth stock with significant upside. He bases …”
CMCompass Pathways23“The YouTuber suggests buying Compass Pathways as a calculated speculation due to its potential for significant…”
ITIntegrys21“The YouTuber recommends Integrys for its supply of ultra-pure chemicals and materials essential for advanced c…”
ADADPT19“The YouTuber identifies Adaptive Biotech Technologies (ADPT) as a potential 10x stock by 2030, based on a patt…”
HIHims & Hers17“The YouTuber argues that Hims is significantly undervalued, trading at 13 times free cash flow while growing r…”
TX10X Genomics16“The YouTuber is highly excited about 10X Genomics, a leader in spatial biology that allows scientists to under…”
ABAbbott Laboratories13“The YouTuber suggests Abbott Laboratories as a potential long-term dividend stock. They note its fair financia…”
ATATAI Life Sciences7“The YouTuber recommends ATAI Life Sciences as a 'diversified play' in the psychedelic therapy market. Unlike C…”
GHGH Research6“The YouTuber suggests GH Research as a 'technology bet' in the psychedelic therapy sector, focusing on a compo…”
“The analyst sees tremendous upside potential in Owlet, despite its high-risk profile and recent CEO change. He…”
ISIntuitive Surgical2“The YouTuber suggests reconsidering Intuitive Surgical, highlighting its strong moat primarily from high switc…”
NVNovo Nordisk1“The YouTuber argues Novo Nordisk is historically cheap despite recent negative sentiment due to lowered guidan…”
“The YouTuber argues that Novo Nordisk is significantly undervalued, trading at half the market's price-to-five…”
BSBoston Scientific0“The YouTuber identifies Boston Scientific as a pure Tier 1 robotics company, building physical systems for med…”
ALAlign Technologies0“The YouTuber suggests Align Technologies is a buy due to its current undervaluation, trading at a P/E of aroun…”
CHChemed0“The YouTuber recommends Chemed as a buy, noting its current P/E of 20 is significantly below its historical av…”
SASanofi0“The YouTuber believes Sanofi is a good buying opportunity due to its current undervaluation, evidenced by a lo…”
PFPfizer0“The YouTuber suggests Pfizer is a buy due to its current low valuation (P/E of 12.99, P/B of 1.57) after a sig…”
CNCentene0“The YouTuber identifies Centene as the cheapest stock in the healthcare insurance sector based on his 'value r…”
SMSara Medtec Ter SMTI0“Adriconomics is buying SMTI, a micro-cap healthcare company focused on wound care, because his custom 'value r…”
ELElevance0“The YouTuber states that Elevance is 'extremely cheap' with a value ratio under 10, suggesting it is a good in…”
CLColoplast0“The analyst suggests Coloplast is an interesting value due to its significant price drop, currently trading 40…”
EXExelixis0“The YouTuber intends to build a small position in Exelixis due to its strong position in the oncology market, …”
DXDexcom0“The analyst views Dexcom as a potential bargain after a significant stock drop due to a lowered outlook, which…”
LNLanthus Holdings INC0“The YouTuber suggests Lanthus Holdings is an interesting and potentially cheap stock, trading at a price to fr…”
POInsulet0“The YouTuber sees Insulet as a good entry opportunity despite recent pressure from weight-loss drugs, arguing …”
JNJohnson and Johnson0“The YouTuber highlights Johnson & Johnson as a strong performer within the healthcare sector during past marke…”
WBWalgreens0“The YouTuber advises investors to continue avoiding Walgreens, labeling it a 'value trap.' He argues that Amaz…”
IQIQVIA0“The YouTuber suggests IQVIA, trading 42.5% below its recent high, as a buy. The company is a market leader in …”
VHVanguard Healthcare ETF0“The YouTuber recommends the Vanguard Healthcare ETF (VHT) for diversification within the healthcare sector. Th…”
XLHealthcare Select Sector SPDR fund0“The YouTuber suggests the Healthcare Select Sector SPDR fund (XLV) as a defensive investment, arguing that peo…”
HCHCA Healthcare0“The YouTuber sees a good opportunity to buy HCA Healthcare, a leading US healthcare provider, due to its stron…”
ABAbbVie0“The YouTuber recommends AbbVie, a global biopharmaceutical company, due to its focus on innovative therapies l…”
BABayer AG0“The analyst is currently invested in Bayer and expects a short-term corrective upward movement of 15-35%. Afte…”
VKViking Therapeutics0“The YouTuber is buying Viking Therapeutics, a biopharmaceutical company with promising GLP-1 drugs in trials f…”
SMSummit Therapeutics0“The YouTuber sees Summit Therapeutics as a speculative buy due to its promising cancer drug for non-small cell…”
OWOwlette0“The YouTuber is holding Owlet, a small-cap company with significant share appreciation. He highlights its baby…”
IDIDEX Laboratories0“The YouTuber purchased IDEX Laboratories, a device manufacturer for animal health (livestock and pets). He not…”
DODocimity0“The YouTuber finds Docimity, a niche messaging app for doctors, 'interesting' due to its impressive functional…”
No data yet — the crawler is running.
Why you can trust the ranking
No hype, no cherry-picking — just qualified calls, weighed evenly across every creator we track.Only qualified calls
A named stock, a clear buy or sell stance, and real reasoning. Passing mentions and hype are filtered out.
One vote per creator
Each channel counts once per stock, so a single loud voice can't skew the ranking.
Weighted consensus
We weigh how many creators agree, how convinced they are, and how recent each call is.
FAQ
How is this ranking calculated?
We crawl finance YouTubers, transcribe their videos, and use AI to extract only qualified analyses (named stock + clear direction + real reasoning). Each channel counts once per stock; the ranking weighs consensus, analysis quality, conviction and recency.
What counts as a qualified signal?
A named stock, a clear buy or sell stance, and real reasoning — valuation, fundamentals, a catalyst or a technical setup. Passing mentions and hype with no argument are ignored.
How often is the data updated?
We crawl the tracked finance YouTubers daily, transcribe new videos, and re-weight the ranking every day — so the most recent, highest-conviction calls rise to the top.
Is YouTuberStocks free?
Yes — it's completely free, and every signal links back to the original video as its source.
Is this financial advice?
Not financial advice. This site aggregates third-party opinions (finance YouTubers) for informational purposes. Do not make investment decisions based on this alone.